Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 39(9): 1205-1215, Sept. 2006.
Article Dans Anglais | LILACS | ID: lil-435426

Résumé

Angiotensin-converting enzyme inhibitors have been shown to improve splanchnic perfusion in distinct shock states. We hypothesized that enalaprilat potentiates the benefits of early fluid resuscitation in severe experimental sepsis, particularly in the splanchnic region. Anesthetized and mechanically ventilated mongrel dogs received an intravenous infusion of live Escherichia coli over a period of 30 min. Thereafter, two interventions were performed: fluid infusion (normal saline, 32 mL/kg over 30 min) and enalaprilat infusion (0.02 mg kg-1 min-1 for 60 min) in randomized groups. The following groups were studied: controls (fluid infusion, N = 4), E1 (enalaprilat infusion followed by fluid infusion, N = 5) and E2 (fluid infusion followed by enalaprilat infusion, N = 5). All animals were observed for a 120 min after bacterial infusion. Mean arterial pressure, cardiac output (CO), portal vein blood flow (PVBF), systemic and regional oxygen-derived variables, and lactate levels were measured. Rapid and progressive reductions in CO and PVBF were induced by the infusion of live bacteria, while minor changes were observed in mean arterial pressure. Systemic and regional territories showed a significant increase in oxygen extraction and lactate levels. Widening venous-arterial and portal-arterial pCO2 gradients were also detected. Fluid replacement promoted transient benefits in CO and PVBF. Enalaprilat after fluid resuscitation did not affect systemic or regional hemodynamic variables. We conclude that in this model of normotensive sepsis inhibition of angiotensin-converting enzyme did not interfere with the course of systemic or regional hemodynamic and oxygen-derived variables.


Sujets)
Animaux , Mâle , Chiens , Inhibiteurs de l'enzyme de conversion de l'angiotensine/pharmacologie , Infections à Escherichia coli , Énalaprilate/pharmacologie , Choc septique/thérapie , Inhibiteurs de l'enzyme de conversion de l'angiotensine/administration et posologie , Pression sanguine/effets des médicaments et des substances chimiques , Débit cardiaque/effets des médicaments et des substances chimiques , Modèles animaux de maladie humaine , Énalaprilate/administration et posologie , Traitement par apport liquidien/méthodes , Perfusions veineuses , Acide lactique/sang , Veine porte/effets des médicaments et des substances chimiques , Débit sanguin régional/effets des médicaments et des substances chimiques , Réanimation/méthodes , Indice de gravité de la maladie
2.
Braz. j. med. biol. res ; 38(6): 873-884, June 2005. ilus, tab, graf
Article Dans Anglais | LILACS | ID: lil-402673

Résumé

We investigated the systemic and regional hemodynamic effects of early crystalloid infusion in an experimental model of septic shock induced by intravenous inoculation with live Escherichia coli. Anesthetized dogs received an intravenous infusion of 1.2 x 10(10) cfu/kg live E. coli in 30 min. After 30 min of observation, they were randomized to controls (no fluids; N = 7), or fluid resuscitation with lactated Ringer's solution, 16 ml/kg (N = 7) or 32 ml/kg (N = 7) over 30 min and followed for 120 min. Cardiac index, portal blood flow, mean arterial pressure, systemic and regional oxygen-derived variables, blood lactate, and gastric PCO2 were assessed. Rapid and progressive cardiovascular deterioration with reduction in cardiac output, mean arterial pressure and portal blood flow (about 50, about 25 and about 70 percent, respectively) was induced by the live bacteria challenge. Systemic and regional territories showed significant increases in oxygen extraction and in lactate levels. Significant increases in venous-arterial (about 9.6 mmHg), portal-arterial (about 12.1 mmHg) and gastric mucosal-arterial (about 18.4 mmHg) PCO2 gradients were also observed. Early fluid replacement, especially with 32 ml/kg volumes of crystalloids, promoted only partial and transient benefits such as increases of about 76 percent in cardiac index, of about 50 percent in portal vein blood flow and decreases in venous-arterial, portal-arterial, gastric mucosal-arterial PCO2 gradients (7.2 ± 1.0, 7.2 ± 1.3 and 9.7 ± 2.5 mmHg, respectively). The fluid infusion promoted only modest and transient benefits, unable to restore the systemic and regional perfusional and metabolic changes in this hypodynamic septic shock model.


Sujets)
Animaux , Chiens , Mâle , Infections à Escherichia coli/traitement médicamenteux , Hémodynamique/effets des médicaments et des substances chimiques , Solution isotonique/administration et posologie , Choc septique/traitement médicamenteux , Modèles animaux de maladie humaine , Traitement par apport liquidien/méthodes , Débit sanguin régional/effets des médicaments et des substances chimiques , Choc septique/microbiologie , Facteurs temps
SÉLECTION CITATIONS
Détails de la recherche